[Preprint] Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact – medRxiv Related: Explanations for ‘long Covid’ remain elusive. For now, believing patients and treating symptoms is the best doctors can do – STAT AND Long COVID: who is at risk? – The Conversation Commentary on Twitter How long is #LongCovid?The […]
The post [Preprint] Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact appeared first on Links Medicus.
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study – The Lancet Commentaries: Most patients hospitalized for Covid-19 still have symptoms six months later, China study finds AND Long-term follow-up of recovered patients with COVID-19 – The Lancet Commentary on Twitter Largest #LongCovid cohort @TheLancet just published:6 months post-hospital, —76% still […]
The post Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital appeared first on Links Medicus.
[Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility
International trials of blood thinners in critically ill COVID-19 patients pause due to futility – NIH News Releases Commentary on Twitter The 3 largest RCTs of therapeutic #anticoagulation for #COVID19 pts in the ICU have ALL been stopped early for futility. (@remap_cap @ATTACC_COVID & #ACTIV4) Nothing published yet, but given the large n of […]
The post [Press release – results not published yet] International trials of blood thinners in critically ill COVID-19 patients pause due to futility appeared first on Links Medicus.
Sinovac vaccine 78% effective in Brazil trial, experts call for more details
Sinovac vaccine 78% effective in Brazil trial, experts call for more details – Reuters See also: Brazil announces ‘fantastic’ results for Chinese-made COVID-19 vaccine, but details remain sketchy – Science
The post Sinovac vaccine 78% effective in Brazil trial, experts call for more details appeared first on Links Medicus.
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data – The BMJ Opinion
The post Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data appeared first on Links Medicus.
Moderna COVID-19 vaccine phase III trial results published; it is 94.1% efficacious in preventing symptomatic COVID-19
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine – New England Journal of Medicine Commentaries: Peer-reviewed report on Moderna COVID-19 vaccine publishes – NIH News Releases AND Peer-reviewed data show high protection for leading COVID vaccines – CIDRAP AND The Moderna Vaccine’s Antibodies May Not Last As Long As We Hoped – Forbes Commentary […]
The post Moderna COVID-19 vaccine phase III trial results published; it is 94.1% efficacious in preventing symptomatic COVID-19 appeared first on Links Medicus.
Debate: Should we delay second vaccine doses to give one dose of the Covid-19 vaccine to more people?
Editorial: U.S. COVID-19 Vaccination Challenges Go Beyond Supply – Annals of Internal Medicine Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment – Annals of Internal Medicine A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose – Annals of Internal Medicine Alternative Dose Allocation Strategies to Increase […]
The post Debate: Should we delay second vaccine doses to give one dose of the Covid-19 vaccine to more people? appeared first on Links Medicus.
New SARS-CoV-2 variants: increased transmissibility likely to cause more deaths and possibly a new wave of the disease
SARS-CoV-2 Variants – World Health Organization Why epidemiologists are so worried about the new Covid-19 variants, in 2 charts – Vox We lost to SARS-CoV-2 in 2020. We can defeat B-117 in 2021 – STAT Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data – Imperial College of London AND […]
The post New SARS-CoV-2 variants: increased transmissibility likely to cause more deaths and possibly a new wave of the disease appeared first on Links Medicus.
Randomized trial: Neutralizing monoclonal antibody not efficacious among hospitalized patients with covid-19
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 – New England Journal of Medicine Commentaries: Covid-19: Trial of LY-CoV555 Stopped for Futility – Physician’s Weekly AND Results of NIH-sponsored ACTIV-3 trial published – NIH News Releases AND Bamlanivimab Flops in Hospitalized COVID-19 Patients – MedPage Today (free registration required)
The post Randomized trial: Neutralizing monoclonal antibody not efficacious among hospitalized patients with covid-19 appeared first on Links Medicus.
[Preprint] Randomized trial: Arthritis drugs improve survival in critically ill patients with Covid-19
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report – medRxiv Commentaries: Covid-19: Arthritis drugs improve survival in intensive care patients, shows study – The BMJ AND Arthritis drugs could help save lives of Covid patients, research finds – The Guardian AND Expert comment – Two potentially life-saving drugs for critically ill COVID-19 patients […]
The post [Preprint] Randomized trial: Arthritis drugs improve survival in critically ill patients with Covid-19 appeared first on Links Medicus.